GreenBank Capital Inc. announced that tests carried out to ISO standards by a leading independent laboratory have confirmed that CodiKoat's first product that uses its world-leading technology is dramatically effective in killing the Covid- 19 virus. In rigorous laboratory tests carried out to ISO 21702:2019 standards at University College London under the auspices of the university's highly-regarded Virology Research Services arm, the CodiKoat-treated acetate film was found to kill 90% of the human coronavirus within 2 seconds and over 99% within 10 seconds. CodiKoat's own tests show that the technology will destroy not only Covid-19 and all its mutations, but also all other viruses and bacteria, as well as any likely future pandemic threatening viruses. CodiKoat's technology works by using surface-functionalised nanostructures to inactivate viruses within seconds of contact. It also has the same effect on bacteria and fungi. CodiKoat have developed a high-precision coating process to apply their product in a highly controllable and uniform manner. This provides a strong chemistry of nanostructures with the surface, which leads to high durability, lasting for the whole product lifetime. CodiKoat technology can coat any surface -- be it hard or soft, rough or smooth, curved or flat -- with nanoparticles of any composition and size. CodiKoat materials can be easily tuned at an atomic scale and integrated into existing manufacturing lines for any product. Any surface or product treated with the CodiKoat application immediately becomes a Covid- destroying medium that within seconds destroys Covid-19 and any other existing and novel viruses and bacteria on contact. This effect lasts for the whole product lifetime with stunning implications for mass-use products and high footfall venues; from smart phone surfaces (which apparently can have more viral and bacterial load than toilet seats) to hospital environments and food hygiene. In the US alone, hospital-acquired infections are thought to cost the US economy upwards of USD 30bn a year - and that was before the emergence of Covid-19. Coating hospital surfaces and instruments with CodiKoat would offer the prospect of dramatically reducing these costs by radically reducing the incidence of hospital-acquired infections. CodiKoat believe that smart phone and touch screen manufacturers will also want to incorporate the CodiKoat product into their manufacturing processes so that their phones will be entirely virus and bacteria free for the entire lifetime of the product. The potential uses for the revolutionary CodiKoat product are virtually endless. GreenBank has completed the purchase of its initial stake in CodiKoat pursuant to its announcement of May 4, 2021. Final results of testing on Codikoat's next product, an antiviral face mask, are still awaited.